JAVIER
PUENTE VÁZQUEZ
Profesor asociado de Ciencias de la Salud
Memorial Sloan Kettering Cancer Center
Nueva York, Estados UnidosPublicaciones en colaboración con investigadores/as de Memorial Sloan Kettering Cancer Center (4)
2024
2023
-
Characterization and Management of Adverse Reactions From the CLEAR Study in Advanced Renal Cell Carcinoma Treated With Lenvatinib Plus Pembrolizumab
Oncologist, Vol. 28, Núm. 6, pp. 501-509
-
Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer
Journal of Clinical Oncology, Vol. 41, Núm. 18, pp. 3339-3351
2022
-
Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial
The Lancet Oncology, Vol. 23, Núm. 3, pp. 362-373